More Pharma v. Drugmakers
REITERATIONFacts
The Antecedents: The Del Mundo Group owned 50% of E.A. Northam, which distributed pharmaceutical products manufactured by Drugmakers Laboratories, Inc. (Drugmakers), controlled by Eliezer Del Mundo. The Santillana Group, through Alberto Santillana, owned the other 50%. An Agreement dated May 31, 1993, stipulated that the Del Mundo Group would cede their shares to the Santillana Group, but the pharmaceutical products would remain jointly owned by Eliezer/Drugmakers, exclusively manufactured by Drugmakers, and sold to S.V. More Pharma Corporation (S.V. More), controlled by Alberto. On the same date, E.A. Northam executed a Deed of Sale/Assignment with S.V. More, transferring distributorship rights, with the condition that products be manufactured by Drugmakers per their Contract Manufacturing Agreement (CMA) expiring October 1993. Procedural History: In September 1993, Drugmakers proposed a new manufacturing agreement, which S.V. More found unacceptable. S.V. More requested a copy of the CMA from Drugmakers for its License to Operate renewal but did not receive it. Consequently, on October 23, 1993, S.V. More entered into a Contract to Manufacture Pharmaceutical Products (CMPP) with Hizon Laboratories, Inc. (Hizon Laboratories), and had them manufacture some of the products. The Bureau of Food and Drug (BFAD) issued Certificates of Product Registration (CPR) with S.V. More as distributor and Hizon Laboratories as manufacturer. Drugmakers and Eliezer filed a Complaint for Breach of Contract, Damages, and Injunction against S.V. More, Alberto, Hizon Laboratories, and its President, Rafael Hizon, Jr. The Regional Trial Court (RTC) ruled in favor of Drugmakers, finding S.V. More and Alberto liable for breach of contract and ordering them, along with Hizon Laboratories and Rafael, to pay actual damages, moral damages, exemplary damages, attorney's fees, and costs. The RTC disregarded the defense that certain provisions were surreptitiously inserted, noting Alberto's admission of reviewing the contracts. The RTC also found Hizon Laboratories and Rafael guilty of bad faith. Petitioners appealed. The Court of Appeals (CA) affirmed the RTC ruling with modification, deleting the award for moral and exemplary damages and absolving Hizon Laboratories and Rafael. The CA found that S.V. More breached its contractual obligation by contracting with Hizon Laboratories. Petitioners filed further motions for reconsideration, which were denied, leading to the present consolidated petitions. The Petition: Petitioners assail the CA's affirmation of their liability for breach of contract.
Issue(s)
Whether the Court of Appeals correctly affirmed petitioners' liability for breach of contract, and the propriety of the award of damages and attorney's fees.
Ruling
The consolidated petitions are partly meritorious. The Court affirmed the existence of a breach of contract but modified the award of damages.
Ratio Decidendi
On Whether the Court of Appeals correctly affirmed petitioners' liability for breach of contract, and the propriety of the award of damages and attorney's fees: The Court affirmed the CA's finding that petitioners breached their contractual obligation regarding Drugmakers' exclusive manufacturing status. S.V. More contracted with Hizon Laboratories without Drugmakers' prior written consent, violating the CMA, Agreement, and Deed of Sale/Assignment. This breach occurred for seven days before the CMA expired. However, the Court found the CA's award of ₱6,000,000.00 in actual damages for loss of profits to be erroneous due to an improper factual basis, as the breach only lasted seven days and only affected six out of 28 products. The sales projection was based on unregistered sales invoices and a desired profit margin, lacking competent proof. Consequently, the award of actual damages was set aside. Considering the respondents suffered some pecuniary loss, the Court awarded ₱100,000.00 as temperate damages under Article 2224 of the Civil Code. The Court upheld the CA's award of attorney's fees because the respondents were compelled to litigate to protect their rights and interests.
Main Doctrine
A breach of contract occurs when a party fails to comply with the terms of the agreement. In cases where pecuniary loss is suffered but the amount cannot be proved with certainty, temperate damages may be awarded. Actual damages for loss of profits require proof with reasonable certainty based on competent evidence.